AccessPak for HIV PEP Expanded with Kaletra and Liver disease
Result of checking the interaction of drug AccessPak for HIV PEP Expanded with Kaletra and disease Liver disease for safety when used together.
When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.
Consumer:There are no data concerning the use of tenofovir disoproxil fumarate in patients with hepatic impairment. Tenofovir and tenofovir disoproxil are not metabolized by liver enzymes. However, since tenofovir is not entirely eliminated by the kidney (70% to 80%), tenofovir pharmacokinetics may be altered in patients with impaired hepatic function.
- "Product Information. Viread (tenofovir)." Gilead Sciences, Foster City, CA.
Generic Name: emtricitabine / lopinavir / ritonavir / tenofovir
Brand Name: AccessPak for HIV PEP Expanded with Kaletra
Synonyms: n.a.
AccessPak for HIV PEP Expanded with Kaletra - choroba wątroby 
AccessPak for HIV PEP Expanded with Kaletra - doença hepática 
AccessPak for HIV PEP Expanded with Kaletra - penyakit hati 
AccessPak for HIV PEP Expanded with Kaletra - penyakit hati 
AccessPak for HIV PEP Expanded with Kaletra - malattia del fegato 
AccessPak for HIV PEP Expanded with Kaletra - maladie du foie 
AccessPak for HIV PEP Expanded with Kaletra - Leber erkrankung 
AccessPak for HIV PEP Expanded with Kaletra - enfermedad del higado 
AccessPak for HIV PEP Expanded with Kaletra - заболевание печени 
AccessPak for HIV PEP Expanded with Kaletra - karaciğer hastalığı 
AccessPak for HIV PEP Expanded with Kaletra - مرض الكبد 
AccessPak for HIV PEP Expanded with Kaletra - 肝病